Pharmacology for Nurses

study guides for every class

that actually explain what's on your next test

Ulcerative Colitis

from class:

Pharmacology for Nurses

Definition

Ulcerative colitis is a chronic inflammatory bowel disease that affects the large intestine, causing inflammation and ulceration of the inner lining of the colon. It is characterized by periods of flare-ups and remission, and can significantly impact a person's quality of life.

congrats on reading the definition of Ulcerative Colitis. now let's actually learn it.

ok, let's learn stuff

5 Must Know Facts For Your Next Test

  1. Ulcerative colitis is an autoimmune disorder, where the body's immune system attacks the lining of the colon, leading to chronic inflammation and the formation of ulcers.
  2. The primary symptoms of ulcerative colitis include diarrhea, abdominal pain, rectal bleeding, and an urgent need to have a bowel movement.
  3. Immunosuppressants, biologics, and monoclonal antibodies are commonly used to manage the symptoms and inflammation associated with ulcerative colitis.
  4. Biosimilar drugs, which are highly similar to the original biological drugs, can also be used to treat ulcerative colitis as a more cost-effective alternative.
  5. Urinary antispasmodics, antimuscarinics, and anticholinergics may be prescribed to manage the gastrointestinal symptoms and complications of ulcerative colitis, such as diarrhea and bowel spasms.

Review Questions

  • Explain how immunosuppressants, biologics, and monoclonal antibodies are used to manage ulcerative colitis.
    • Immunosuppressants, such as azathioprine and 6-mercaptopurine, work by suppressing the overactive immune response that drives the inflammation in ulcerative colitis. Biologics, like anti-TNF agents (e.g., infliximab, adalimumab), and monoclonal antibodies, like vedolizumab, target specific inflammatory pathways to reduce inflammation and induce remission. These medications help control the symptoms, promote healing of the colon, and prevent flare-ups in patients with ulcerative colitis.
  • Describe the role of the small and large intestines in the pathogenesis of ulcerative colitis.
    • Ulcerative colitis primarily affects the large intestine, or colon, causing inflammation and ulceration of the inner lining. This leads to the characteristic symptoms of diarrhea, abdominal pain, and rectal bleeding. The inflammation often starts in the rectum and can progressively extend upward through the colon. While the small intestine is typically not affected, severe cases of ulcerative colitis can sometimes involve the last segment of the small intestine, known as the terminal ileum. The inflammation and disruption of the normal intestinal function can significantly impact nutrient absorption and overall gastrointestinal health.
  • Analyze how urinary antispasmodics, antimuscarinics, and anticholinergics may be used to manage the complications of ulcerative colitis.
    • Ulcerative colitis can lead to various gastrointestinal complications, such as diarrhea and bowel spasms, which can significantly impact a patient's quality of life. Urinary antispasmodics, antimuscarinics, and anticholinergics may be prescribed to help alleviate these symptoms. These medications work by reducing intestinal muscle contractions and relaxing the smooth muscle of the gastrointestinal tract, thereby reducing diarrhea, abdominal cramps, and other disruptive bowel movements. By managing the secondary complications of ulcerative colitis, these drugs can improve the patient's overall comfort and well-being, complementing the primary treatment with immunosuppressants, biologics, and monoclonal antibodies.
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Glossary
Guides